Journal of the Society for Cardiovascular Angiography & Interventions最新文献

筛选
英文 中文
Navigating Treble Clef Aorta: A Challenge for Transfemoral Transcatheter Aortic Valve Replacement—A Case Report
Journal of the Society for Cardiovascular Angiography & Interventions Pub Date : 2025-02-01 DOI: 10.1016/j.jscai.2024.102492
Helen S. Anwar MD , José M. Montero-Cabezas MD, PhD , Frank Van Der Kley MD, PhD
{"title":"Navigating Treble Clef Aorta: A Challenge for Transfemoral Transcatheter Aortic Valve Replacement—A Case Report","authors":"Helen S. Anwar MD ,&nbsp;José M. Montero-Cabezas MD, PhD ,&nbsp;Frank Van Der Kley MD, PhD","doi":"10.1016/j.jscai.2024.102492","DOIUrl":"10.1016/j.jscai.2024.102492","url":null,"abstract":"<div><div>Transcatheter aortic valve replacement (TAVR) has emerged as a widely approved intervention for managing severe aortic stenosis. As the number of patients undergoing TAVR continues to rise, certain cases present unique challenges, particularly in relation to vascular access. This report highlights a case of successful transfemoral TAVR performed in a patient with an exceptionally tortuous and elongated aortic arch, characterized by significant curvature reminiscent of the treble clef musical symbol.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 2","pages":"Article 102492"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143428831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Point-of-Care Ultrasound for the Detection of Vascular Access Site Complications—The ULTRASITCOM Study
Journal of the Society for Cardiovascular Angiography & Interventions Pub Date : 2025-02-01 DOI: 10.1016/j.jscai.2024.102516
Pietro Di Santo MD , Omar Abdel-Razek MD, MSc , Graeme Prosperi-Porta MD , Pouya Motazedian MD , Pascal Thériault-Lauzier MD , Saad Alhassani MD , Lee H. Sterling MDCM , Simon Parlow MD , Marie-Eve Mathieu MD , Richard G. Jung MD, PhD , Baylie Morgan BScN , Doug Coyle PhD , Dean A. Fergusson PhD , Kwadwo Kyeremanteng MD , Rebecca Mathew MD , Marino Labinaz MD , Michael Froeschl MD , Rebecca Hibbert MD , Trevor Simard MD, PhD , Jared G. Bird MD , Benjamin Hibbert MD, PhD
{"title":"Point-of-Care Ultrasound for the Detection of Vascular Access Site Complications—The ULTRASITCOM Study","authors":"Pietro Di Santo MD ,&nbsp;Omar Abdel-Razek MD, MSc ,&nbsp;Graeme Prosperi-Porta MD ,&nbsp;Pouya Motazedian MD ,&nbsp;Pascal Thériault-Lauzier MD ,&nbsp;Saad Alhassani MD ,&nbsp;Lee H. Sterling MDCM ,&nbsp;Simon Parlow MD ,&nbsp;Marie-Eve Mathieu MD ,&nbsp;Richard G. Jung MD, PhD ,&nbsp;Baylie Morgan BScN ,&nbsp;Doug Coyle PhD ,&nbsp;Dean A. Fergusson PhD ,&nbsp;Kwadwo Kyeremanteng MD ,&nbsp;Rebecca Mathew MD ,&nbsp;Marino Labinaz MD ,&nbsp;Michael Froeschl MD ,&nbsp;Rebecca Hibbert MD ,&nbsp;Trevor Simard MD, PhD ,&nbsp;Jared G. Bird MD ,&nbsp;Benjamin Hibbert MD, PhD","doi":"10.1016/j.jscai.2024.102516","DOIUrl":"10.1016/j.jscai.2024.102516","url":null,"abstract":"<div><h3>Background</h3><div>Recent technological advancements have expanded access to ultrasound technology. Invasive cardiac procedures come with risks of vascular access complications, necessitating efficient detection methods for dangerous complications such as pseudoaneurysms. Current clinical practice has relied on physical examination, and often requires formal diagnostic imaging to diagnose these complications. The ULTRAsound Assessment of Access SITe COMplications study assessed the diagnostic accuracy of point-of-care ultrasound (POCUS) as an adjunct to physical examination for the detection of pseudoaneurysms following invasive cardiac procedures.</div></div><div><h3>Methods</h3><div>We conducted a single-center study that enrolled patients who underwent invasive cardiovascular procedures with suspected access site complications. Cardiology fellows were trained on the use of POCUS by a radiologist with expertise in vascular imaging. The primary outcome focused on the diagnostic odds ratio (DOR) of combined clinical and POCUS assessments compared to Doppler ultrasound or computed tomography.</div></div><div><h3>Results</h3><div>Among 111 participants, most were female (59.5%), with a mean age of 72.2 years, and with transfemoral access being most prevalent (67.6%). A total of 15 participants were found to have a pseudoaneurysm on formal diagnostic imaging. The combined clinical and POCUS assessments were highly sensitive and demonstrated superior DOR for detecting pseudoaneurysms compared to the physical examination alone (DOR 42.6 [95% CI, 34.6-50.6] vs 15.6 [95% CI, 11.7-19.5]; <em>P</em> &lt; .01).</div></div><div><h3>Conclusions</h3><div>Point-of-care ultrasound is a highly sensitive tool for detecting pseudoaneurysms following invasive cardiovascular procedures. These findings suggest the potential integration of POCUS into routine practice, which could result in timely complication identification and management, thereby improving patient outcomes and reducing health care costs.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 2","pages":"Article 102516"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143428832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stage E Cardiogenic Shock: Hold 'Em, Fold 'Em, or Double Down?
Journal of the Society for Cardiovascular Angiography & Interventions Pub Date : 2025-02-01 DOI: 10.1016/j.jscai.2024.102498
Alexander G. Truesdell MD , Aditya Mehta MD , Ilan Vavilin MD
{"title":"Stage E Cardiogenic Shock: Hold 'Em, Fold 'Em, or Double Down?","authors":"Alexander G. Truesdell MD ,&nbsp;Aditya Mehta MD ,&nbsp;Ilan Vavilin MD","doi":"10.1016/j.jscai.2024.102498","DOIUrl":"10.1016/j.jscai.2024.102498","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 2","pages":"Article 102498"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143428915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rotational Angiography 3D Data Set to Confirm Harmony Valve Fitness Post Pulmonary Artery Plication
Journal of the Society for Cardiovascular Angiography & Interventions Pub Date : 2025-02-01 DOI: 10.1016/j.jscai.2024.102518
Osamah Aldoss MD , Thomas Panicucci DNP , Bassel Mohammad Nijres MD , Mohsen Karimi MD
{"title":"Rotational Angiography 3D Data Set to Confirm Harmony Valve Fitness Post Pulmonary Artery Plication","authors":"Osamah Aldoss MD ,&nbsp;Thomas Panicucci DNP ,&nbsp;Bassel Mohammad Nijres MD ,&nbsp;Mohsen Karimi MD","doi":"10.1016/j.jscai.2024.102518","DOIUrl":"10.1016/j.jscai.2024.102518","url":null,"abstract":"<div><div>A 28-year-old woman presented with heart failure symptoms secondary to severe pulmonary valve regurgitation in the setting of congenital pulmonary valve stenosis that required balloon valvuloplasty. Computed tomography angiography fit analysis demonstrated a severely dilated main pulmonary artery that did not meet the minimum oversizing criteria for placement of a 25-mm Harmony transcatheter pulmonary valve. A hybrid transcatheter pulmonary valve placement approach took place, and a post main pulmonary artery plication right ventricle rotational angiogram was performed. The patient underwent a successful transcatheter pulmonary valve placement. The 3D rotational angiography data set was analyzed, and fit analysis demonstrated an adequate oversizing of the 25-mm transcatheter pulmonary valve.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 2","pages":"Article 102518"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143428921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating Procedural Performance: A Composite Outcome for Atrial Septal Defect and Patent Ductus Arteriosus Closures
Journal of the Society for Cardiovascular Angiography & Interventions Pub Date : 2025-02-01 DOI: 10.1016/j.jscai.2024.102459
Oliver M. Barry MD , Babar S. Hasan MBBS , Nadeem Aslam MBBS , Sarosh P. Batlivala MD, MSCI , Matthew A. Crystal MD , Sara M. Trucco MD , Todd Gudausky MD , Ralf J. Holzer MD , Jacqueline Kreutzer MD , George Nicholson MD , Michael L. O’Byrne MD, MSCE , Brian P. Quinn MD , Surendranath R. Veeram Reddy MD , Arash Salavitabar MD , Brian A. Boe MD
{"title":"Evaluating Procedural Performance: A Composite Outcome for Atrial Septal Defect and Patent Ductus Arteriosus Closures","authors":"Oliver M. Barry MD ,&nbsp;Babar S. Hasan MBBS ,&nbsp;Nadeem Aslam MBBS ,&nbsp;Sarosh P. Batlivala MD, MSCI ,&nbsp;Matthew A. Crystal MD ,&nbsp;Sara M. Trucco MD ,&nbsp;Todd Gudausky MD ,&nbsp;Ralf J. Holzer MD ,&nbsp;Jacqueline Kreutzer MD ,&nbsp;George Nicholson MD ,&nbsp;Michael L. O’Byrne MD, MSCE ,&nbsp;Brian P. Quinn MD ,&nbsp;Surendranath R. Veeram Reddy MD ,&nbsp;Arash Salavitabar MD ,&nbsp;Brian A. Boe MD","doi":"10.1016/j.jscai.2024.102459","DOIUrl":"10.1016/j.jscai.2024.102459","url":null,"abstract":"<div><h3>Background</h3><div>Technical success (TS) and procedural safety (PS) have been reported individually for transcatheter atrial septal defect (ASD) and patent ductus arteriosus (PDA) closures. A composite procedural performance (PP) metric as a patient-centered strategy has not been developed or studied.</div></div><div><h3>Methods</h3><div>A multicenter expert working group created PP metrics for ASD and PDA device closures as a composite of TS and PS. TS criteria were defined and categorized into 3 classes (optimal, satisfactory, and unsatisfactory). PS was defined using established adverse event (AE) definitions from the Congenital Cardiac Catheterization Project on Outcomes (C3PO) registry. PP was divided into 3 outcome classes (I to III). Retrospective C3PO data were collected for all cases of isolated ASD and PDA closure from 2014 through 2017. Exclusion criteria included complex congenital heart disease, significant comorbidities, ASD patients with multiple defects or ≥2 deficient rims, and PDA patients weighing &lt;6 kg or with pulmonary hypertension. Factors correlating with class III (suboptimal) PP were analyzed.</div></div><div><h3>Results</h3><div>A total of 542 ASD and 688 PDA closure cases were included. Most ASD cases (99%) had optimal or satisfactory TS while 1% had a high severity AE. Class III PP occurred in 2% of ASD cases, mostly due to new mitral valve insufficiency. There were no identified patient or procedural factors associated with class III PP for ASD closures. Optimal or satisfactory TS occurred in 98% of PDA cases, with high severity AEs in &lt;1%. Class III PP occurred in 2% of PDA cases, predominantly due to new arch obstruction, and was associated with younger age (<em>P</em> &lt; .001) and lower weight (<em>P</em> = .001).</div></div><div><h3>Conclusions</h3><div>This study introduces PP as a composite variable to comprehensively measure outcomes of standard-risk ASD and PDA device closure. The incorporation of both TS and PS aims to better reflect patient outcomes compared to individual measurements alone. PP may serve as a valuable tool for identifying areas for further investigation and quality improvement.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 2","pages":"Article 102459"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143428833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dual Antiplatelet Therapy Duration Following Percutaneous Coronary Intervention: Time for a Change
Journal of the Society for Cardiovascular Angiography & Interventions Pub Date : 2025-02-01 DOI: 10.1016/j.jscai.2024.102510
Dean J. Kereiakes MD
{"title":"Dual Antiplatelet Therapy Duration Following Percutaneous Coronary Intervention: Time for a Change","authors":"Dean J. Kereiakes MD","doi":"10.1016/j.jscai.2024.102510","DOIUrl":"10.1016/j.jscai.2024.102510","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 2","pages":"Article 102510"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143428942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Utility and Validation of SCAI-CSWG Stages in Patients With Acute Myocardial Infarction-Related Cardiogenic Shock
Journal of the Society for Cardiovascular Angiography & Interventions Pub Date : 2025-01-01 DOI: 10.1016/j.jscai.2024.102461
Rajesh Rajan MD , Mohammed Al Jarallah MD , Amin Daoulah MD , Prashanth Panduranga MD , Ahmed Elmahrouk MD , Abeer Said Mohamed Al Rawahi MD , Said Al Maashani MD , Hatem M. Aloui MD , Mubarak Abdulhadi Aldossari MD , Nooraldaem Yousif MD , Husam A. Noor MD , Abdulrahman Arabi MD , Gi Eun Kim MD , Mohamad Safieh MD , Wael Almahmeed MD , Hassan Khan MD , Mohammed A. Qutub MD , Mohammed Alshehri MD , Amr A. Arafat MD , Omar Kanbr MD , Abdullah N. AlAwadi MD
{"title":"The Utility and Validation of SCAI-CSWG Stages in Patients With Acute Myocardial Infarction-Related Cardiogenic Shock","authors":"Rajesh Rajan MD ,&nbsp;Mohammed Al Jarallah MD ,&nbsp;Amin Daoulah MD ,&nbsp;Prashanth Panduranga MD ,&nbsp;Ahmed Elmahrouk MD ,&nbsp;Abeer Said Mohamed Al Rawahi MD ,&nbsp;Said Al Maashani MD ,&nbsp;Hatem M. Aloui MD ,&nbsp;Mubarak Abdulhadi Aldossari MD ,&nbsp;Nooraldaem Yousif MD ,&nbsp;Husam A. Noor MD ,&nbsp;Abdulrahman Arabi MD ,&nbsp;Gi Eun Kim MD ,&nbsp;Mohamad Safieh MD ,&nbsp;Wael Almahmeed MD ,&nbsp;Hassan Khan MD ,&nbsp;Mohammed A. Qutub MD ,&nbsp;Mohammed Alshehri MD ,&nbsp;Amr A. Arafat MD ,&nbsp;Omar Kanbr MD ,&nbsp;Abdullah N. AlAwadi MD","doi":"10.1016/j.jscai.2024.102461","DOIUrl":"10.1016/j.jscai.2024.102461","url":null,"abstract":"<div><h3>Background</h3><div>Outcomes of patients with acute myocardial infarction–related cardiogenic shock (AMICS) stratified by the Society for Cardiovascular Angiography &amp; Interventions (SCAI) shock stages in the Gulf region are not well known.</div></div><div><h3>Methods</h3><div>We analyzed data from patients with AMICS presenting to multiple centers across the Gulf region between January 2020 and December 2022. Patients were grouped according to SCAI-Cardiogenic Shock Working Group classification: group 1 (SCAI shock stages B/C) and group 2 (SCAI shock stages D/E). Primary end points were survival at 6, 12, 18, and 24 months. Both univariate and multivariate statistical methods were employed in the analysis.</div></div><div><h3>Results</h3><div>A total of 1513 patients from the Gulf Cardiogenic Shock registry, were included with 31.1% in group 1 and 68.9% in group 2. The median follow-up was 6 months. Survival rates in group 1 were 87%, 72%, 56%, and 48% at 6, 12, 18, and 24 months, respectively, whereas group 2 exhibited survival rates of 66%, 29%, 14%, and 4%, respectively, over the same periods. Survival progressively declined with advancing SCAI shock stages, with stage B having the highest survival rates and stage E the lowest (<em>P</em> &lt; .001). Multivariable Cox regression analysis identified higher SCAI stages as strong predictors of increased mortality, with patients in group 2 having a more than 3-fold higher risk of mortality compared to those in group 1 (hazard ratio, 3.13; 95% CI, 2.40-4.07; <em>P</em> &lt; .001). Additionally, lower left ventricular ejection fraction, advanced age, and the presence of tachyarrhythmias were associated with increased mortality risk.</div></div><div><h3>Conclusions</h3><div>This is the first study to validate SCAI-Cardiogenic Shock Working Group stages in a large cohort of patients with AMICS. The SCAI shock staging classification was significantly associated with higher short- and long-term mortality in this cohort, with patients in more advanced stages (D/E) experiencing markedly worse survival outcomes. These findings underscore the utility of SCAI staging in stratifying long-term risk among AMICS patients in the Gulf region. Identification of cardiogenic shock patients at SCAI stages D and E with early hemodynamic monitoring and treating them aggressively with newer mechanical circulatory support in the early stages may improve patient survival.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 1","pages":"Article 102461"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143168527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Mechanical Aspiration Thrombectomy in Patients With Acute Pulmonary Embolism: Results From the Prospective APEX-AV Trial
Journal of the Society for Cardiovascular Angiography & Interventions Pub Date : 2025-01-01 DOI: 10.1016/j.jscai.2024.102463
Mona Ranade MD , Malcolm T. Foster III MD , Paul S. Brady MD , Seth I. Sokol MD , Sabah Butty MD , Andrew Klein MD , Robert Maholic DO , Ammar Safar MD , Taral Patel MD , David Zlotnick MD , Daniel Gans MD , Jeffrey Pollak MD , Dean Ferrera DO , Brian Stegman MD , Sukhdeep Basra MD , John Moriarty MD , Brent Keeling MD , APEX-AV Investigators
{"title":"Novel Mechanical Aspiration Thrombectomy in Patients With Acute Pulmonary Embolism: Results From the Prospective APEX-AV Trial","authors":"Mona Ranade MD ,&nbsp;Malcolm T. Foster III MD ,&nbsp;Paul S. Brady MD ,&nbsp;Seth I. Sokol MD ,&nbsp;Sabah Butty MD ,&nbsp;Andrew Klein MD ,&nbsp;Robert Maholic DO ,&nbsp;Ammar Safar MD ,&nbsp;Taral Patel MD ,&nbsp;David Zlotnick MD ,&nbsp;Daniel Gans MD ,&nbsp;Jeffrey Pollak MD ,&nbsp;Dean Ferrera DO ,&nbsp;Brian Stegman MD ,&nbsp;Sukhdeep Basra MD ,&nbsp;John Moriarty MD ,&nbsp;Brent Keeling MD ,&nbsp;APEX-AV Investigators","doi":"10.1016/j.jscai.2024.102463","DOIUrl":"10.1016/j.jscai.2024.102463","url":null,"abstract":"<div><h3>Background</h3><div>There is a need for additional data to assess procedural efficacy and risks associated with mechanical thrombectomy for treating pulmonary embolism (PE) due to its increased utilization and diversity of patient populations presenting with PE. This study evaluated the safety and efficacy of percutaneous mechanical aspiration thrombectomy with the AlphaVac F18<sup>85</sup> System (AngioDynamics) in patients with acute intermediate-risk PE.</div></div><div><h3>Methods</h3><div>Patients with acute intermediate-risk PE and a right ventricular (RV)/left ventricular (LV) diameter ratio of ≥0.9 were eligible for enrollment in this prospective, multicenter, single-arm study. The primary effectiveness end point was reduction in the RV/LV ratio at 48 hours. The primary safety end point was the rate of major adverse events (MAEs) defined as subjects who experienced major bleeding, device-related deaths, clinical deterioration, or pulmonary vascular or cardiac injury within 48 hours postprocedurally.</div></div><div><h3>Results</h3><div>In total, 122 subjects were enrolled at 25 sites. Mean procedure time was 37.2 ± 17.7 minutes. There were statistically significant reductions in mean 48-hour postprocedural RV/LV diameter ratio (−0.45 ± 0.27; <em>P</em> &lt; .001). Postprocedural mean pulmonary arterial pressure also significantly declined from 27.8 ± 7.8 mm Hg before the procedure to 21.8 ± 7.2 mm Hg (<em>P</em> &lt; .001). There was a 35.5% mean reduction in clot burden as measured by the modified Miller index score. Five (4.1%) subjects developed 7 MAEs during the postprocedural 48-hour assessment period, the majority of which were access site bleeding.</div></div><div><h3>Conclusions</h3><div>Percutaneous mechanical aspiration thrombectomy with the AlphaVac system provided a safe and effective treatment for acute intermediate-risk PE with a significant reduction in RV/LV ratio and clot burden with a low rate of adverse events.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 1","pages":"Article 102463"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143168862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addition by Subtraction: A Novel Device for Pulmonary Embolus Thrombectomy
Journal of the Society for Cardiovascular Angiography & Interventions Pub Date : 2025-01-01 DOI: 10.1016/j.jscai.2024.102508
Joseph M. Kim MD , Eric A. Secemsky MD, MSc
{"title":"Addition by Subtraction: A Novel Device for Pulmonary Embolus Thrombectomy","authors":"Joseph M. Kim MD ,&nbsp;Eric A. Secemsky MD, MSc","doi":"10.1016/j.jscai.2024.102508","DOIUrl":"10.1016/j.jscai.2024.102508","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 1","pages":"Article 102508"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143168863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Endovascular Interventions for the Treatment of Superficial Femoral Artery Disease: A Network Meta-analysis
Journal of the Society for Cardiovascular Angiography & Interventions Pub Date : 2025-01-01 DOI: 10.1016/j.jscai.2024.102432
Andrew W. Schwartz BS , Yousuf Shah MD , Haocheng Huang MS , Ashwin Nathan MD, MSHP , Alexander C. Fanaroff MD, MHS , Jay S. Giri MD, MPH , Sahil A. Parikh MD , Alexandra J. Lansky MD , Tayyab Shah MD
{"title":"Comparison of Endovascular Interventions for the Treatment of Superficial Femoral Artery Disease: A Network Meta-analysis","authors":"Andrew W. Schwartz BS ,&nbsp;Yousuf Shah MD ,&nbsp;Haocheng Huang MS ,&nbsp;Ashwin Nathan MD, MSHP ,&nbsp;Alexander C. Fanaroff MD, MHS ,&nbsp;Jay S. Giri MD, MPH ,&nbsp;Sahil A. Parikh MD ,&nbsp;Alexandra J. Lansky MD ,&nbsp;Tayyab Shah MD","doi":"10.1016/j.jscai.2024.102432","DOIUrl":"10.1016/j.jscai.2024.102432","url":null,"abstract":"<div><h3>Background</h3><div>To understand the relative safety and efficacy of endovascular treatment modalities used for superficial femoral artery (SFA) disease, we performed a network meta-analysis to compare outcomes between percutaneous transluminal angioplasty (PTA), atherectomy (A), bare metal stent (BMS), brachytherapy/radiotherapy, covered stent graft (CSG), cutting balloon angioplasty (CBA), drug-coated balloon (DCB), drug-eluting stent (DES), and intravascular lithotripsy (L).</div></div><div><h3>Methods</h3><div>We performed a systematic literature search of PubMed from January 2000 to January 2023 to identify randomized trials comparing endovascular interventions for the treatment of SFA disease. The primary end points were technical success and 12-month primary patency.</div></div><div><h3>Results</h3><div>In total, 57 studies (9089 patients) were included. The mean age of the included patients was 68.4 years, 41.4% had diabetes, 18.3% had critical limb ischemia, and 81.3% had de novo lesions. A mean of 1.2 lesions were treated per patient. Technical success was superior for CSG, BMS, and A+DCB compared with PTA, while A+DCB and CSG were superior to DCB. All interventions except brachytherapy alone had superior primary patency compared with PTA. There were no significant differences in 12-month mortality or major amputation. All interventions except L+DCB, PTA+A, and CBA were superior to PTA regarding target lesion revascularization, while only DCB, DES, and BMS were better than PTA at improving Rutherford classification.</div></div><div><h3>Conclusions</h3><div>In SFA disease, PTA alone is mostly inferior to other endovascular techniques. This comparison of other endovascular techniques will be valuable for endovascular device selection in the treatment of SFA disease.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 1","pages":"Article 102432"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143168864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信